恩华药业

- 002262

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
恩华药业(002262) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入414,546.31276,339.81135,756.57504,150.45365,598.52
营业收入414,546.31276,339.81135,756.57504,150.45365,598.52
二、营业总成本299,590.86203,408.29103,680.83391,201.88266,005.44
营业成本108,807.2675,996.7139,670.69136,984.3198,315.86
营业税金及附加5,409.393,678.171,867.196,800.044,928.19
销售费用125,156.9982,972.1843,702.81173,700.41110,129.27
管理费用17,866.8911,489.474,733.7320,711.5715,153.60
财务费用-1,216.66-878.38-635.57-1,926.09-992.69
研发费用43,566.9930,150.1414,341.9954,931.6338,471.21
资产减值损失----------
公允价值变动收益----------
投资收益4,337.602,085.191,138.715,104.353,731.37
其中:对联营企业和合营企业的投资收益684.94343.03421.71963.98540.25
汇兑收益----------
三、营业利润117,139.3473,255.3830,487.13118,234.42100,545.69
加:营业外收入256.02184.41182.28674.7263.58
减:营业外支出2,155.541,340.54695.802,044.73531.78
其中:非流动资产处置损失----------
四、利润总额115,239.8372,099.2529,973.61116,864.41100,077.48
减:所得税费用13,586.119,441.893,509.7413,439.6811,736.02
五、净利润101,653.7262,657.3626,463.88103,424.7388,341.47
归属于母公司所有者的净利润102,010.7162,892.0326,528.22103,691.8188,564.13
少数股东损益-356.99-234.67-64.35-267.08-222.66
六、每股收益
基本每股收益(元/股)1.01000.62000.26001.03000.8800
稀释每股收益(元/股)1.01000.62000.26001.03000.8800
七、其他综合收益-------634.89--
八、综合收益总额101,653.7262,657.3626,463.88102,789.8488,341.47
归属于母公司所有者的综合收益总额102,010.7162,892.0326,528.22103,056.9288,564.13
归属于少数股东的综合收益总额-356.99-234.67-64.35-267.08-222.66
下载全部历史数据到excel中 返回页顶